Adult obesity in the United States continues to rise, and being obese increases the risk of severe illness in people with COVID-19, the U.S. Centers for Disease Control and Prevention warns.
Obesity in pregnant women may impact the development of their offspring's brains, according to a study published online Aug. 10 in the Journal of Child Psychology and Psychiatry.
New research shows that an intensive lifestyle intervention (ILI) aimed at weight loss lowered incidence of obesity-related cancers in adults with overweight or obesity and type 2 diabetes, according to a study published online in Obesity, the flagship journal of The Obesity Society.
Most antidepressant medicines cause weight gain as a side effect. Bupropion is an antidepressant that may lead to weight loss in some people. In this article, we discuss antidepressants that cause weight loss. We also look at the benefits and risks of antidepressants for weight loss and consider alternative options.
Even light alcohol consumption linked to higher risk of obesity and metabolic syndrome in study of 27 million adults
Consuming more than half a standard alcoholic drink a day (equivalent to 7g of pure alcohol) is associated with an increased risk of obesity and metabolic syndrome in both men and women, and the risk rises in proportion with alcohol intake, according to a nationwide study involving nearly 27 million adults (aged 20 years and older) from South Korea, being presented at The European and International Congress on Obesity (ECOICO), held online this year.
For those who can overcome fears of surgery and perhaps do battle with recalcitrant insurers, there remains another very successful option that experts say is currently vastly underused. That option is bariatric surgery, an approach that is now simpler, safer and more effective than in its early days in the 1990s.
Gastric bypass surgery is the most effective therapy to treat or reverse type 2 diabetes in severely obese patients. Many achieve remission of diabetes following surgery and no longer require diabetes medications.
For an underserved primary care population, a high-intensity lifestyle-based treatment program for obesity results in significant weight loss at 24 months, according to a study published in the Sept. 3 issue of the New England Journal of Medicine.
With so much misinformation surrounding obesity, Dr. Catherine Varney is careful with her words. First of all, she clarifies that her patients are not obese, but rather have obesity, which is a disease and not a lack of willpower.
Altered gene expression in fat tissue may help explain why individuals who have regained weight after weight loss surgery still experience benefits such as metabolic improvements and a reduced risk of type 2 diabetes. The findings come from a study published in the Journal of Internal Medicine.